ClinicalTrials.Veeva

Menu

Evaluation of the EpiGlare Tester for the Measurement of Glare-Induced Changes in BSCVA in Subjects With and Without Cataracts

E

Epico, LLC

Status

Completed

Conditions

Cataract

Treatments

Device: Glare Testing

Study type

Observational

Funder types

Industry

Identifiers

Details and patient eligibility

About

The EpiGlare Tester will identify visual disability resulting from the glare experienced by subjects with cataracts in the glare-induced change in best spectacle corrected visual acuity (BSCVA).

Full description

Inclusion Criteria:

  1. Are 18 years of age or older.

  2. Have been evaluated by an opthalmologist and have a lens determination of either Normal or Cataract in each eye based on slit lamp examination.

    1. Normal = lens opacity of clear or trace
    2. Cataract = lens opacity of 2+ or greater
  3. Have written informed consent as required by the site's IRB and received a copy.

  4. Are willing and able to comply with testing according to the Investigator.

Exclusion Criteria:

  1. Best corrected visual acuity is worse than 20/60 in either eye
  2. Have occular pathology including corneal or macular disease or advanced glaucoma
  3. Have cognitive dysfunction which limits the ability to cooperate with testing.
  4. Have presence or history of any other condition or finding or concomitant medication that, in the investigator's opinion, makes the subject unsuitable as a candidate for EpiGlare or study participation or may confound the outcome of the study.

Enrollment

89 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

clear lenses OU cataracts OU willing to comply with testing

Exclusion criteria

BCVA < 20/63 either eye ocular pathology (ie corneal, macular disease, advanced glaucoma) cognitive dysfunction other conditions that in the investigators opinion made the subject unsuitable candidate

Trial design

89 participants in 2 patient groups

Cataract
Description:
Patients with bilateral cataracts with Lens grade 2+ or greater, cataract classification nuclear, cortical or posterior subcapsular
Treatment:
Device: Glare Testing
Non-Cataract
Description:
patients with bilateral clear lenses (no cataracts)
Treatment:
Device: Glare Testing

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems